![Graham Lumsden](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Graham Lumsden
Chief Executive Officer at
BioMarck Pharmaceuticals Ltd.
Profile
Graham George Lumsden is currently the President & Chief Executive Officer at BioMarck Pharmaceuticals Ltd. and a Member at the Royal College of Veterinary Surgeons.
He previously served as the Chief Executive Officer & Executive Director at Motif BioSciences, Inc., Chief Executive Officer at Tiemed LLC, Director at Immutep Ltd., Non-Executive Director at Motif Bio Plc, and Principal at Merck & Co., Inc. and Carnethy Consulting LLC.
Lumsden received his undergraduate degree from The Royal School of Veterinary Studies in 1982.
Graham Lumsden active positions
| Companies | Position | Start |
|---|---|---|
Royal College of Veterinary Surgeons
 Royal College of Veterinary Surgeons Miscellaneous Commercial ServicesCommercial Services Functions as the regulatory body for veterinary surgeons in the United Kingdom | Corporate Officer/Principal | - |
BioMarck Pharmaceuticals Ltd.
 BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new drugs for the treatment of pulmonary diseases and disorders | Chief Executive Officer | 05/01/2021 |
Former positions of Graham Lumsden
| Companies | Position | End |
|---|---|---|
| MOTIF BIO PLC | Chief Executive Officer | 04/05/2020 |
Tiemed LLC | Chief Executive Officer | 01/01/2014 |
Carnethy Consulting LLC | Corporate Officer/Principal | 01/01/2014 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2001 |
| IMMUTEP LIMITED | Director/Board Member | - |
Training of Graham Lumsden
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
89
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Motif BioSciences, Inc.
 Motif BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Develops antibiotics for life-threatening infections | Health Technology |
BioMarck Pharmaceuticals Ltd.
BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new drugs for the treatment of pulmonary diseases and disorders | Health Technology |
Royal College of Veterinary Surgeons
Royal College of Veterinary Surgeons Miscellaneous Commercial ServicesCommercial Services Functions as the regulatory body for veterinary surgeons in the United Kingdom | Commercial Services |
Immutep Ltd.
 Immutep Ltd. BiotechnologyHealth Technology Engages in the development of anti-cancer therapeutics | Health Technology |
Motif Bio Plc
 Motif Bio Plc Pharmaceuticals: MajorHealth Technology Develops antibiotics designed to be effective against serious and life-threatening infections | Health Technology |
Tiemed LLC | |
Carnethy Consulting LLC | |
The Royal School of Veterinary Studies
 The Royal School of Veterinary Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Graham Lumsden
